The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISAL 2025 | Looking forward to ISAL 2025
Marion Subklewe, MD, Ludwig-Maximilians-University of Munich, Munich, Germany, shares her excitement for the 19th International Symposium on Acute Leukemias (ISALXIX), taking place on March 16-19, 2025, in Munich, Germany. The program features cutting-edge topics ranging from basic science and translational research to clinical applications in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
